Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.

Angelo Andriulli, Rocco Clemente, Luigi Solmi, Vittorio Terruzzi, Renzo Suriani, Angelo Sigillito, Gioacchino Leandro, Pietro Leo, Giovanni De Maio, Francesco Perri

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences